| Acino Pharma AG - Dexlansoprazole-Acino 30 mg, Kapseln mit veränderter Wirkstofffreisetzung | | 67981 | | 01 | | Dexlansoprazole-Acino 30 mg | | Kapseln mit veränderter Wirkstofffreisetzung | | A02BC06 | | Dexlansoprazole | | 16.09.2020 | | |
| | Composition | | dexlansoprazolum 30 mg, sacchari sphaerae 28.8 mg, magnesii carbonas, saccharum 41.5 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, hypromellosum, talcum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, acidi methacrylici copolymerum A, acidi methacrylici copolymerum B, macrogolum 8000, polysorbatum 80, silica colloidalis anhydrica, triethylis citras, E 171, Kapselhülle: carrageenanum, kalii chloridum, E 132 et E 133, E 171, E 172 (nigrum), aqua purificata, hypromellosum, E 172 (rubrum), E 172 (flavum), E 133, cera carnauba, lacca, glyceroli mono-oleas, pro capsula. | | Packungsbestandteile | | Kapseln mit veränderter Wirkstofffreisetzung | | | | Principe actif | Concentr. |
|---|
| Dexlansoprazolum | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Acidi Methacrylici | | | | Acidi Methacrylici Copolymerum A | | | | Acidi Methacrylici Copolymerum B | | | | Aqua Purificata | | | | Carrageenanum | | Kapselhülle | | Cera Carnauba | | | | E 132 | | color. | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Ethylis Acrylatis Polymerisatum Dispersio | 30 | | | Glyceroli Mono-Oleas | | | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | | | Potassium Chlorure | | | | Lacca | | | | Macrogol | 8000 | | | Magnesii Carbonas | | | | Per Centum | | | | Polysorbatum 80 | | | | Pro Capsula | | | | Sacchari Sphaerae | 28.8 mg | | | Saccharum | 41.5 mg | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | Triethylis Citras | | |
|
| |
|
